Our respiratory panel testing assesses for infections caused by 22 viruses and bacteria, including COVID-19, influenza A and B, and RSV. Learn more. https://bit.ly/3BsbCI2
About us
As the global reference laboratory for Mayo Clinic, Mayo Clinic Laboratories will help you advance patient care, strengthen your practice, and broaden access to specialized testing. Through our partnerships with clinicians at Mayo Clinic and health care providers around the world, we are able to offer the most sophisticated test catalog in the world. It is because of these daily collaborations that our subspecialized laboratories continue to be a critical component to patient care at Mayo Clinic. - 4.5 million patients worldwide - 3,000 plus tests and pathology services - 24 million tests performed annually - 4,500 physicians and scientists at Mayo Clinic - 90 plus subspecialty pathologists - 560 peer-reviewed articles published annually
- Website
-
http://www.mayocliniclabs.com
External link for Mayo Clinic Laboratories
- Industry
- Hospitals and Health Care
- Company size
- 1,001-5,000 employees
- Headquarters
- Rochester, Minnesota
- Type
- Privately Held
- Founded
- 1971
Locations
-
Primary
Get directions
3050 Superior Dr NW
Rochester, Minnesota 55901, US
Employees at Mayo Clinic Laboratories
Updates
-
Many cases of encephalopathy previously considered infectious are now recognized to have an autoimmune cause. Our full suite of testing can pinpoint the cause and facilitate personalized therapy selection. https://bit.ly/4fvVwee
Autoimmune Encephalopathy Testing - Mayo Clinic Laboratories
news.mayocliniclabs.com
-
Faster diagnosis means faster treatment. The UBA1Q assay offers quick turnaround times, aiding in rapid screening and diagnosis for VEXAS syndrome. Learn more. https://bit.ly/3BBIwpt
VEXAS syndrome - Insights
news.mayocliniclabs.com
-
Mayo Clinic Laboratories was the first lab to offer clinical quantitation of risankizumab. Now, our new panel includes that test in parallel with a unique bridging immunoassay for anti-risankizumab antibodies. Learn more in this test-specific episode of our "Answers From the Lab" podcast. https://bit.ly/41H8uCH
Panel Boosts Therapeutic Monitoring of IBD Drug: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D. - Insights
news.mayocliniclabs.com
-
Ongoing research has begun to shed light on women’s unique healthcare needs, which has resulted in new efforts to help women improve their health. Learn about Mayo Clinic Laboratories' advancements in women's health testing in this "Eye on Innovation." https://bit.ly/3ZYsO15
-
Mayo Clinic Laboratories' enhanced tumor panel broadens the spectrum of variants that can be detected to better profile tumor pathogenesis. Learn how this guides targeted cancer therapy. https://bit.ly/3ZIPyAR
Enhanced Solid Tumor NGS Panel Broadens Genetic-Variants Detection: Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S. - Insights
news.mayocliniclabs.com
-
Prepare for the unexpected. Listen to Jane Hermansen, outreach manager at Mayo Clinic Laboratories, and outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton discuss key strategies for maintaining operations during disruptions. https://bit.ly/4fEPaJP
How to Minimize Operational Disruptions in an Outreach Program - Insights
news.mayocliniclabs.com
-
What’s driving the rapid acceleration of AI advancements and what's next? Listen to this episode of “Answers From the Lab” with host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Bill Morice, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. https://bit.ly/3ZEUirk
-
Our targeted testing for hereditary gastrointestinal conditions delivers individualized insights to improve outcomes. https://bit.ly/3P0EWIM
Genetic testing - Insights
news.mayocliniclabs.com
-
Direct ethanol testing accurately assesses alcohol use and alcohol use disorder, guiding better treatment plans and supporting recovery. Learn more. https://bit.ly/3ZYV4Ra
Ethanol testing in primary care - Insights
news.mayocliniclabs.com